List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 XIFAXAN
1.2.3 Viberzi
1.2.4 Lotronex
1.2.5 Other
1.3 Market by Sales Channel
1.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
2.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region (2023-2028)
2.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region
2.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2017-2022)
2.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers
3.1.1 Global Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2021
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers
3.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue in 2021
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2028)
4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type
4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type
4.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2017-2022)
4.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Type (2023-2028)
5 Market Size by Sales Channel
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
5.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historical Sales by Sales Channel (2017-2022)
5.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Sales by Sales Channel (2023-2028)
5.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2017-2028)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel
5.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historical Revenue by Sales Channel (2017-2022)
5.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Revenue by Sales Channel (2023-2028)
5.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2017-2028)
5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Sales Channel
5.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Sales Channel (2017-2022)
5.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Sales Channel (2023-2028)
6 North America
6.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type
6.1.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2028)
6.1.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2017-2028)
6.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Sales Channel
6.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2028)
6.2.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2017-2028)
6.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
6.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2028)
6.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type
7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2028)
7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2017-2028)
7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Sales Channel
7.2.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2028)
7.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2017-2028)
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
7.3.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2028)
7.3.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type
8.1.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Sales Channel
8.2.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2028)
8.2.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2017-2028)
8.3 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region
8.3.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type
9.1.1 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2028)
9.1.2 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2017-2028)
9.2 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Sales Channel
9.2.1 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2028)
9.2.2 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2017-2028)
9.3 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
9.3.1 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2028)
9.3.2 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type
10.1.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Sales Channel
10.2.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2017-2028)
10.2.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2017-2028)
10.3 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
10.3.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bausch Health
11.1.1 Bausch Health Corporation Information
11.1.2 Bausch Health Overview
11.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bausch Health Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Sebela Pharmaceuticals
11.3.1 Sebela Pharmaceuticals Corporation Information
11.3.2 Sebela Pharmaceuticals Overview
11.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sebela Pharmaceuticals Recent Developments
11.4 Astellas Pharmaceuticals
11.4.1 Astellas Pharmaceuticals Corporation Information
11.4.2 Astellas Pharmaceuticals Overview
11.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Astellas Pharmaceuticals Recent Developments
11.5 Amneal Pharms
11.5.1 Amneal Pharms Corporation Information
11.5.2 Amneal Pharms Overview
11.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Amneal Pharms Recent Developments
11.6 Pharscin Pharma
11.6.1 Pharscin Pharma Corporation Information
11.6.2 Pharscin Pharma Overview
11.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pharscin Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Chain Analysis
12.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Mode & Process
12.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Marketing
12.4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Channels
12.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors
12.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Trends
13.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers
13.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges
13.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints
14 Key Findings in The Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
